Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Grifols sees revenues rise after diagnostics boost

This article was originally published in Clinica

Executive Summary

Spain’s largest healthcare company Grifols saw sales increase by around 15% during the first nine months of 2009 after it was boosted by increased revenue from its diagnostics division. The firm recorded a 20% increase in diagnostics sales to €76.2m ($114.1m) during the nine-month period. Sales of Grifols’ reagents were the main drivers behind this increase. The group, which also develops pharma products, recorded overall revenue for the nine months of €689.6m, up from €600.2m during the same period the previous year. Overall net profit for the period was €117.1m, an improvement on €92.9m recorded in the first nine months of 2008.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts